Photo from Steven Frank/X
May 29, 2024, 09:13
Steven Frank: Phase III Level I evidence for proton therapy in head and neck malignancies to be presented at ASCO
Steven Frank, Executive Director of Particle Therapy Institute at MD Anderson Cancer Center, shared on X:
“Congratulations to all participating institutions for driving Phase III Level I evidence for proton therapy in head and neck malignancies to be presented at ASCO on June 4th.” .
View additional information.
Source: Steven Frank/X